<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: Despite recent reports linking <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> with increased risk of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and complications, there is limited data on patients with diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to evaluate the incidence and associations of <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> in 210 patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with and without diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Renal, liver, <z:chebi fb="23" ids="18059">lipid</z:chebi> profile and HbA(1c) were measured </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> status was determined by measuring 25-dihydroxyvitamin D </plain></SENT>
<SENT sid="4" pm="."><plain>Presence or absence of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> was determined and early-morning urine microalbumin:<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio was measured </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were assessed clinically using <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> symptom score, <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> disability score and nerve conduction study </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Eighty-seven patients had diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> and these patients had significantly longer duration of <z:mp ids='MP_0002055'>diabetes</z:mp> and higher HbA(1c) </plain></SENT>
<SENT sid="7" pm="."><plain>Age, gender, incidence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> were not significantly different from those without <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Mean (SD) <z:chebi fb="27" ids="27300">vitamin D</z:chebi> was significantly lower in those with <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> [36.9 (39.9) nmol/l] compared with those without [58.32 (58.9) nmol/l] and 81.5% of patients with <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> had <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> compared with 60.4% of those without </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> showed significant (P &lt; 0.05) correlations with total cholesterol, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> and urine microalbumin:<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio </plain></SENT>
<SENT sid="10" pm="."><plain>Binary logistic regression analysis showed that diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> was significantly associated with <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> (odds ratio = 3.47; 95% CI = 1.04-11.56, P = 0.043) after inclusion of potential confounders such as duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, HbA(1c) and <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> is an independent risk factor for diabetic <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo>, and further studies are required to confirm if <z:chebi fb="27" ids="27300">Vitamin D</z:chebi> supplementation could prevent or delay the <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
</text></document>